Riskpilot← Back to searchSign inGet full accessMaxhälsa Tand & Kropp AB
ABActiveOrg 5566461256Villavallen 20Dental practice care activities · NACE 8623Est. 20030 employees
Revenue 2024
SEK 5,4M
+4% vs 2023
EBITDA margin
6.6%
+320% vs 2023
Equity ratio
24.7%
Financial strength
Net profit 2024
SEK 186K
+564% vs 2023
| Revenue | SEK 5,4M | +4% |
| EBITDA | SEK 357K | +320% |
| Net profit | SEK 186K | +564% |
| Total assets | SEK 2M | -6% |
| Equity | SEK 486K | -12% |
| Employees | 0 | — |
Legal name
Maxhälsa Tand & Kropp AB
Org number
5566461256
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
15 juli 2003
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva tandläkarpraktik och läkarmottagning ävensom idka därmed förenlig verksamhet.
Address
Villavallen 20
Email
info@maxhalsa.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 230 | 5 427 | 4 622 | 5 158 | 5 381 |
| Staff expenses | — | — | −3 284 | — | — |
| EBITDA | 945 | 544 | 248 | 85 | 357 |
| Depreciation & amort. | −123 | −160 | −138 | −123 | −109 |
| EBIT | 822 | 384 | 110 | −38 | 248 |
| Net financials | — | −1 | −1 | — | 4 |
| Profit before tax | 602 | 444 | 104 | 46 | 252 |
| Tax | −176 | −72 | −50 | −18 | −66 |
| Net profit | 426 | 372 | 54 | 28 | 186 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 575 | 2 503 | 1 987 | 2 087 | 1 968 |
| Equity | 997 | 969 | 523 | 551 | 486 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 793 | 809 | 734 | 892 | 837 |
| Total debt | 793 | 809 | 734 | 892 | 837 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20202024
Equity ratio
24.7%
This company
38.2%
Market median
-35% vs market
20202024
Return on equity
38.3%
This company
18.4%
Market median
+108% vs market
20202024
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20202024
Asset turnover
2.73×
This company
1.12×
Market median
+144% vs market
20202024
Debt / equity
3.05×
This company
0.62×
Market median
-392% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2022 – 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Maxhälsa Tand & Kropp AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kerstin Elisabeth Nordenham Murby | Audit | 0 companies |
| Mohamed Ward Ghanoum | Deputy Board Member | 0 companies |
| Bachar Ghanoum | Board of Directors | 0 companies |
| Dima Jasser | Board of Directors | 0 companies |